Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for socket preservation after tooth extraction
RBR-6jvvp9tPhase 3Completed
- Sponsor
- ILAPEO
- Start
- Sep 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of teriparatide in Alveolar bone atrophy (ABL) and edentulism (2 arms), sponsored by ILAPEO. Started Sep 2024; status: completed.
02
Drugs
teriparatide
03
Conditions
Alveolar bone atrophy (ABL)edentulism
Beyond the preview
Go deeper on RBR-6jvvp9t.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6jvvp9t.